By MEDELPHARM S.A.S
To get in touch with MEDELPHARM S.A.S, simply fill out the form below.
Subscribe to Supplier
MEDELPHARM hosts successful STYL’One webinar on dry granulation
Beynost, France: – Research-based manufacturer and tableting specialists MEDELPHARM S.A.S. has recorded high registration and participation for the latest webinar in its ‘My STYL’One’ series, this time focusing on formulation methods for dry granulation and dry coating.
The MEDELPHARM webinar “Dry Granulation Formulation Development: How to save time and cost with roll compaction mimicking” was hosted online during the afternoon of October 27, 2021.
More than 600 people used the online registration for the free webinar, with actual online participation of more than 340 attendants.
Dry formulation insights
The session was presented by Dr. Hannah Lou Keizer, Deputy Head of Production at Pohl-Boskamp, a formulation specialist that has become one of Germany’s most successful mid-sized pharmaceutical companies. Co-host was Head of MEDELPHARM Science Lab and Business Development Manager Bruno Leclercq.
Together, they covered the key aspects of dry granulation for roll compaction in pharmaceutical process, using data from Dr. Keizer’s research on hybrid modeling of roll compaction using the with the STYL’One Evo development tableting press.
They also presented case studies highlighting benefits of dry granulation mimicking on a compaction simulator.
The hour-long webinar concluded with a 25 minute Question & Answer session.
“The Q&A session threw up a lot of very interesting questions,” commented Medelpharm Communications Director Ingrid Coyle.
“This confirmed the very expert nature of this audience, including formulation and galenic scientists, oral and solid dosage form specialists, scale-up and tech transfer engineers, technical support staff, researchers and regulators,” Ms. Coyle noted.
“In the final analysis, we left our audience with three very clear take-out messages: that compaction simulators can be used for mimicking the roll compaction process, that correct machine parameters for roll compaction can be determined using very small amounts of material, and that it is possible to mimic the whole downstream process – from powder to tablet,” she concluded.
Founded in 1985 in Lyon, France, MEDELPHARM has more than 35 years of experience in the tableting sector. Among other initiatives, the precision engineering company designs and manufactures research & development compaction simulators, and provides innovative solutions for powder analysis and formulation support.
Staffed by a dedicated team of scientists and technicians, the MEDELPHARM Science Lab performs trials with predictive results and supports its customers with formulation and powder characterization challenges. In addition, MEDELPHARM Distribution also represents a range of solutions in powder processing, from R&D to production.
For more information, visit: www.medelpharm.com.